Evidence map›Paper›PMID 26547912›Full record

SynthesisAdvances in therapy2015

A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory Diseases.

Eleni Vangeli, Savita Bakhshi, Anna Baker, Abigail Fisher, Delaney Bucknor, Ulrich Mrowietz, Andrew J K Östör, Laurent Peyrin-Biroulet, Ana P Lacerda, John Weinman

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in Advances in therapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 2 pooled it
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 2 syntheses or guidelines pooled it, 156 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Medication adherence, health outcomes, and perceived social performance in Black Americans receiving hemodialysis.Health psychology : official journal of the Division of Health Psychology, American Psychological Association · 2026
    Article
  8. Article
  9. Medication adherence and real-world factors of first line induction treatment selection in ANCA-associated vasculitis.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 5 countries.

Eleni VangeliDepartment of Psychology, London South Bank University, London, UK.
Savita BakhshiPsychological Medicine, King's College London, London, UK.
Anna BakerAtlantis Healthcare, London, UK.
Abigail FisherUniversity College London, London, UK.
Delaney BucknorLondon Metropolitan University, London, UK.
Ulrich MrowietzPsoriasis-Center at the Department of Dermatology, University Medical Center of Schleswig-Holstein, Campus Kiel, Germany.
Andrew J K ÖstörSchool of Clinical Medicine, University of Cambridge, Cambridge, UK.
Laurent Peyrin-BirouletInserm U954 and Department of Gastroenterology, Université de Lorraine, Vandoeuvre-les-Nancy, France.
Ana P LacerdaAbbVie Inc, North Chicago, IL, USA.
John WeinmanInstitute of Pharmaceutical Science, King's College London, 5th Floor, Franklin-Wilkins Building, 150 Stamford Street, London, SE1 9NH, UK. John.weinman@kcl.ac.uk.
King's College London · GBAbbVie (United States) · USAtlantic Healthcare (United Kingdom) · GBChristian-Albrechts-Universität zu Kiel · DEInserm · FRLondon Metropolitan University · GBLondon South Bank University · GBUniversity College London · GBUniversity of Cambridge · GB

Funding

Cancer Research UK 14133
6 · The paper itself

Abstract

backgroundNon-adherence impacts negatively on patient health outcomes and has associated economic costs. Understanding drivers of treatment adherence in immune-mediated inflammatory diseases is key for the development of effective strategies to tackle non-adherence.

objectiveTo identify factors associated with treatment non-adherence across diseases in three clinical areas: rheumatology, gastroenterology, and dermatology.

designSystematic review. DATA SOURCES: Articles published in PubMed, Science Direct, PsychINFO and the Cochrane Library from January 1, 1980 to February 14, 2014. STUDY SELECTION: Studies were eligible if they included patients with a diagnosis of rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, inflammatory bowel disease, or psoriasis and included statistics to examine associations of factors with non-adherence. DATA EXTRACTION: Data were extracted by the first reviewer using a standardized 23-item form and verified by a second/third reviewer. Quality assessment was carried out for each study using a 16-item quality checklist.

results73 studies were identified for inclusion in the review. Demographic or clinical factors were not consistently associated with non-adherence. Limited evidence was found for an association between non-adherence and treatment factors such as dosing frequency. Consistent associations with adherence were found for psychosocial factors, with the strongest evidence for the impact of the healthcare professional-patient relationship, perceptions of treatment concerns and depression, lower treatment self-efficacy and necessity beliefs, and practical barriers to treatment.

conclusionsWhile examined in only a minority of studies, the strongest evidence found for non-adherence were psychosocial factors. Interventions designed to address these factors may be most effective in tackling treatment non-adherence.

Indexed as

Medication AdherenceArthritisArthritis, PsoriaticArthritis, RheumatoidHumansInflammatory Bowel DiseasesPsoriasisSpondylitis, AnkylosingTreatment OutcomeInflammatory bowel diseasePatient adherencePsoriasisPsoriatic arthritisRheumatology

Identifiers

PMID26547912
PMCPMC4662720
OpenAlexW2125145661

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.